RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,441,000 | -29.3% | 160,615 | -57.7% | 0.02% | -33.3% |
| Q2 2016 | $2,038,000 | +5.3% | 379,484 | -9.8% | 0.02% | -11.1% |
| Q1 2016 | $1,936,000 | -60.1% | 420,864 | -55.0% | 0.03% | -52.6% |
| Q4 2015 | $4,858,000 | -36.5% | 934,283 | -26.2% | 0.06% | -46.2% |
| Q3 2015 | $7,656,000 | -63.3% | 1,265,430 | -4.1% | 0.11% | -63.7% |
| Q2 2015 | $20,839,000 | +81.9% | 1,319,766 | +25.2% | 0.29% | +62.2% |
| Q1 2015 | $11,455,000 | +50.7% | 1,053,829 | +45.8% | 0.18% | +56.5% |
| Q4 2014 | $7,601,000 | +14.9% | 722,563 | +4.8% | 0.12% | +12.7% |
| Q3 2014 | $6,613,000 | -46.0% | 689,592 | -34.9% | 0.10% | -46.0% |
| Q2 2014 | $12,242,000 | +24.9% | 1,059,887 | +8.1% | 0.19% | +14.5% |
| Q1 2014 | $9,803,000 | +121.3% | 980,302 | +188.2% | 0.16% | +146.3% |
| Q4 2013 | $4,429,000 | – | 340,147 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 888,132 | $7,966,000 | 6.12% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 1,054,678 | $9,460,000 | 3.30% |
| Kassirer Asset Management Corp | 363,700 | $3,262,000 | 2.36% |
| WATER ISLAND CAPITAL LLC | 3,359,140 | $30,131,000 | 1.91% |
| Banco BTG Pactual S.A. | 338,889 | $3,040,000 | 1.43% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 1,941,012 | $17,411,000 | 1.41% |
| FIRST NEW YORK SECURITIES LLC /NY | 237,500 | $2,130,375,000 | 1.41% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 3,804,600 | $34,089,000 | 1.25% |
| Atika Capital Management LLC | 300,000 | $2,691,000 | 1.10% |
| Atika Capital Management LLC | 298,200 | $2,672,000 | 1.09% |